Otsuka Pharmaceutical Development & Commercialization, Inc.

This study tested a drug called AVP-786 to see if it could help control disinhibition—acting without thinking—in people with brain diseases like Alzheimer's or frontotemporal dementia. The trial was stopped early after enrolling only one participant, so no conclusions can be draw…

This study tested a drug called AVP-786 to see if it could safely reduce agitation in people with Alzheimer's disease over a long period. It was an extension of earlier studies and included over 1,100 participants. The main goal was to check for side effects, but the study was te…